Artesunate-amodiaquine combination

DRUG3 trials

Sponsors

Centers for Disease Control and Prevention, University of Yaounde 1, London School of Hygiene and Tropical Medicine

Conditions

Malaria, FalciparumMalaria,Falciparum

Phase 2

Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali

CompletedNCT05550909

London School of Hygiene and Tropical MedicineMalaria,Falciparum

Start: 2022-10-17End: 2023-01-26Updated: 2024-10-01

Phase 4

Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde

CompletedNCT04565184

University of Yaounde 1Malaria,Falciparum

Start: 2019-05-09End: 2020-11-30Updated: 2021-04-02

Unknown Phase

Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

CompletedNCT01326754

Centers for Disease Control and PreventionMalaria, Falciparum

Start: 2011-08-31End: 2012-06-30Updated: 2013-02-25

Related Papers

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial.

2024-12-177 citations

Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial

BMC Infectious Diseases2022-02-2114 citations